Celldex Therapeutics, Inc. (CLDX) ownership: Kynam Capital Management, LP 14% · institutions 110% · index and ETF funds 7% (13F 2026-06-30). Insider activity, 90 days: 0 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Wellington Management | 9543671.00 | $355.12M | 12.2% | 2026-06-30 |
| BlackRock | 7002530.00 | $260.56M | 8.9% | 2026-06-30 |
| Kynam Capital Management, LP | 5322908.00 | $198.07M | 6.8% | 2026-06-30 |
| Vanguard | 4984374.00 | $185.47M | 6.3% | 2026-06-30 |
| Price T Rowe Associates Inc | 4685223.00 | $174.34M | 6.0% | 2026-06-30 |
| State Street | 3900427.00 | $145.13M | 5.0% | 2026-06-30 |
| FMR (Fidelity) | 3722888.00 | $138.53M | 4.7% | 2026-06-30 |
| Deep Track Capital, LP | 2939151.00 | $109.37M | 3.7% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 | |
| Sell | null | 2026-06-25 |
Back to CLDX overview · CLDX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.